Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
GRI Bio, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GRI Bio, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GRI Bio, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GRI Bio, Inc.Listing on record | AwardD (derivative) | $20.9K | SEC | ||
GRI Bio, Inc.Listing on record | AwardD (derivative) | $100K | SEC | ||
Matinas BioPharma Holdings, Inc.Listing on record | Buy | $6.8K | conv 62ClusterFirst in 12mo | SEC |